Skip to content

Clinical trials

Observational Heart Failure trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Observational Country / region: Germany Clear all

192 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20044
20053
20062
20079
20085
20097
20106
20119
20123
201312
201418
201510
201611
201714
201811
20196
20208
20216
20225
20239
20249
202510
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Recruiting36
Unknown status23
Terminated13
Active, not recruiting8
Not yet recruiting4
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biotronik SE & Co. KG12
Abbott Medical Devices9
Medtronic9
Boston Scientific Corporation8
Charite University, Berlin, Germany8
University Hospital, Essen7
Heart and Diabetes Center North-Rhine Westfalia6
Universitätsklinikum Hamburg-Eppendorf6
AstraZeneca5
German Heart Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure192
Cardiomyopathies15
Heart Diseases14
Cardiovascular Diseases12
Arrhythmias, Cardiac10
Pulmonary Disease, Chronic Obstructive9
Coronary Artery Disease8
Coronary Disease8
Renal Insufficiency, Chronic8
Diabetes Mellitus, Type 27

Trials

Showing 1 to 25 of 192. Each trial links to its page on Pharma Observatory.

92 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.